<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors retrospectively reviewed the clinicopathologic and immunologic features of 65 consecutive cases of childhood <z:hpo ids='HP_0002665'>lymphoma</z:hpo> reported between 1980 and 1989 </plain></SENT>
<SENT sid="1" pm="."><plain>Southern blot hybridization was also performed in 23 cases to study their association with Epstein-Barr virus (EBV) and human T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> virus type 1 (HTLV-1) </plain></SENT>
<SENT sid="2" pm="."><plain>The 65 cases included 56 non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) (86%) and 9 Hodgkin's disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) (14%) </plain></SENT>
<SENT sid="3" pm="."><plain>The NHL could be classified into the following groups: Group I, small noncleaved cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (20 cases); Group II, lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (17 cases); Group III, large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (17 cases); and miscellaneous (2 cases) </plain></SENT>
<SENT sid="4" pm="."><plain>There was no follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> case </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemical study on paraffin sections and/or frozen specimens in 47 cases of NHL showed that <z:hpo ids='HP_0000001'>all</z:hpo> the Group I cases belonged to B-cell <z:hpo ids='HP_0002664'>neoplasm</z:hpo> (17 of 17 cases); most of the Group II cases belonged to T-cell <z:hpo ids='HP_0002664'>neoplasm</z:hpo> (9 of 14 cases); and most of the Group III cases were peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (PTL) (8 of 16 cases), including 2 cases of Ki-1 <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The majority of <z:e sem="disease" ids="C0220612" disease_type="Neoplastic Process" abbrv="">childhood NHL</z:e> belonged to high-grade <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> with an aggressive clinical course (median survival time, 8 months) </plain></SENT>
<SENT sid="7" pm="."><plain>The EBV DNA could be detected from the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues in 4 of 6 PTL, but in none of the remaining 19 cases of NHL including 6 Burkitt's type <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>HTLV-1 proviral genome was not detected in <z:hpo ids='HP_0000001'>all</z:hpo> specimens examined </plain></SENT>
<SENT sid="9" pm="."><plain>The authors concluded that the distribution pattern and clinicopathologic feature of childhood <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in Taiwan are comparable to that in Japan and western countries </plain></SENT>
<SENT sid="10" pm="."><plain>The frequent association of EBV with aggressive PTL was unique and deserves additional investigation </plain></SENT>
</text></document>